Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.1 (
asparaginase
)
2,695
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Antineoplastic properties of different Schiff bases obtained by the interaction of 5-nitrofuran with substituted pyrimidines have been examined both in vitro and in vivo. In vitro studies on L 5178Y/
asparaginase
sensitive, HL 60 and P 388 cell lines and in vivo studies on the P 388 cell line indicate that all the compounds are potential antineoplastic agents. However, 2-(5-nitro-2-furfurylidene-amino)-pyrimidine (SBP1) is the most effective, and 2-(5-nitro-2-furfurylidene-amino)-6-hydroxypyrimidine (SBP3) is the least effective agent. Doubling time, rates of protein and DNA synthesis inhibition and LD50 values-1,000 mg/kg body weight for SBP1 and 1,275 mg/kg body weight for 2-(5-nitro-2-furfurylidene-amino)-4- methylpyrimidine (
SBP2
)- in the oral route support the activity and use of SBP1 and
SBP2
as future anticancer agents.
...
PMID:Studies on the antineoplasticity of Schiff bases containing 5-nitrofuran and pyrimidine. 221